Navigation Links
Lilly Named Best Company for Blacks in Technology
Date:9/2/2009

INDIANAPOLIS, Sept. 2 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has been given the Epsilon "Star of Highest Magnitude" Award and has been named the best company for blacks in technology by the Black Data Processing Associates (BDPA) and WorkplaceDiversity.com. The Epsilon Award is given annually to the top company in the nation that promotes a workplace and environment that supports the advancement of African-Americans in the information technology industry.

"We are thrilled and honored to have received this award," said Michael Heim, senior vice president of information technology and chief information officer, at Lilly. "This award is proof that Lilly has made, and will continue to make, choices that support our dedication to diversity and ultimately offer better solutions for our employees and patients."

Lilly received the Epsilon Award at the BDPA's annual national conference which was held this month in Raleigh, North Carolina. The first pharmaceutical company to win top honors, this was the fourth consecutive year Lilly was listed as one of the top companies for blacks in technology.

According to the BDPA, a company must attract and recruit the most talented employees, clients and customers as well as realize positive financial results to be considered for this award. Eligible companies also submit a survey related to workforce and supplier diversity within the organization.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Calif., Dec. 6 Pharmacyclics, Inc. (Nasdaq: ... a Phase I/II study showing safety and clinical ... Lymphoma (NHL) treated with its HDAC inhibitor PCI-24781 ... today at the 51st ASH Annual Meeting being ... ,, PCI-24781 is an oral pan-HDAC inhibitor ...
(Date:12/6/2009)... Findings offer hope for future treatments targeting growth factor, ... -- The spread of breast cancer cells from the ... controlled by a growth factor known as TGFb, which ... prevent metastatic breast cancer, British researchers say. , Previous ... regulates normal cell growth and movement. In this new ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...
(Date:12/6/2009)... organizations and members of the community, in cooperation with the Greater ... a holiday party. This year,s attendance is expected to soar to ... , ... (PRWEB) December 6, 2009 -- Volunteer ... VA Healthcare System in West Los Angeles, will once again create ...
(Date:12/5/2009)... ,, What: Cuts for a Cause ... the fight against cancer and other terminal illnesses affecting children. ... to St. Jude Children,s Research Hospital. Guests will enjoy complimentary ... and savory Vietnamese restaurant in Falls Church for all guests. ...
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Breast Cancer's Spread Now Better Understood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3
... April 17 In recognition of the 20th anniversary of ... global hemophilia community by pledging euro 250,000 to the World ... around the world will engage in activities to support the ... and promote support for the needs of people living with ...
... view the likely outcome of breast augmentation surgery before the procedure ... is taking advantage of it. , ... (Vocus) April ... breast surgery is typically: ‘What will I look like after the ...
... TransparencyEL SEGUNDO, Calif., April 17 DaVita Inc., a ... with chronic kidney disease, today acknowledged its being named ... company and only healthcare company to make the 2009 ... in 1999. This is the second year the ...
... team of scientists from the University of Leicester could ... a powerful new strategy for both the early diagnosis ... is to use cutting edge nanotechnology to identify a ... aggressive cancers. , The University of Leicester researchers say ...
... limit prevention of blindness, experts say , , THURSDAY, April ... not prevent the development of blindness-causing macular edema in ... new study has found. , About 50 percent of ... of those with type 2 diabetes develop retinopathy, which ...
... for Statewide Health Information Network for New York ... eHealth Collaborative (NYeC) has partnered with global eHealth ... the country,s largest electronic prescribing network, for an ... with a patient,s consent, deliver prescription history for ...
Other Medicine News:Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 2Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 3Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 4Health News:Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia 5Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 2Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 3Health News:DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999 2Health News:Pioneering medical nanotechnology offers new cancer breakthrough hope 2Health News:Drug May Not Help Diabetes-Related Eye Damage 2Health News:ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY 2Health News:ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY 3Health News:ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY 4
(Date:12/4/2009)... Bayer Diabetes Care today announced the three grand prize winners ... of the Jonas Brothers, selected the winning video entries submitted ... prize is an in-person meeting today with Nick. ... are: Caleb, age 6, from Danbury, CT, who dreams of ...
(Date:12/4/2009)... Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC ... and Trademark Office has allowed its patent application on ... the manufacture of the Company,s DCVax® therapeutic cancer vaccines. ... very high concentration of dendritic cells (which are the ...
(Date:12/4/2009)... Depression, anxiety disorder, bipolar disorder, Attention Deficit ... are among the comorbidities reported to occur more ... diagnosed with epilepsy versus those without an epilepsy ... households across the U.S. ,, Findings from " ...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3International conference on endothelin 9866 1International conference on endothelin 9866 2International conference on endothelin 9866 3Sex talk revelations of the lonely Y chromosome 9861 1Sex talk revelations of the lonely Y chromosome 9861 2Martek Announces Settlement of Patent Dispute with Capsugel France 13980 1Martek Announces Settlement of Patent Dispute with Capsugel France 13980 2
... PGL; Nasdaq: PGLA) today announced additional,data from the Phase ... This data was presented at the 58th Annual Meeting ... in Boston, USA(1). As the Phase 2 trial,s ... analysis described in this presentation was performed to,evaluate the ...
... as many injections as standard therapy, and, demonstrated at least comparable ... impairment of quality of life on treatment -,- ... presented at the Annual Meeting of the American Association for ... the Study of Liver Diseases (AASLD) -, ROCKVILLE, Md., Nov. 5 ...
Other Medicine Technology:Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 2Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 3Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 4Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 5Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 6Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 7Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C 8
Lance shaped gently curved tip. Flat serrated handle with polished finish....
For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model....
Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Medicine Products: